drugset / Trial / NCT05679375

IV and Intrathecal Ketamine in Cesarean Section

NCT05679375 ↗

Phase 4 Completed 60 enrolled Assiut University
NaParallel-groupTriple-blindPrevention

Summary

In the current study, the investigators will compare the effects of low-dose intravenous (i.v.) ketamine versus intrathecal Ketamine added to spinal anesthesia on the time to first request for analgesia and maternal pain scores and overall satisfaction in patients undergoing cesarean section.

Timeline

Start
2023-02-01
Primary completion
2024-10-31
Completion
2024-10-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.1 mg/kg Intrathecal
Comparator Ketamine Small molecule 0.25 mg/kg Intrathecal

Indications

No indication recorded.